US5770198A
(en)
*
|
1988-05-18 |
1998-06-23 |
The Research Foundation Of The State Of New York |
Platelet-specific chimeric 7E3 immunoglobulin
|
US5169930A
(en)
*
|
1990-01-05 |
1992-12-08 |
La Jolla Cancer Research Foundation |
Fibronectin receptor
|
US7132260B2
(en)
*
|
1991-04-05 |
2006-11-07 |
The General Hospital Corporation |
DNA encoding parathyroid hormone receptor
|
US7150974B1
(en)
|
1991-04-05 |
2006-12-19 |
The General Hospital Corporation |
Parathyroid hormone receptor binding method
|
ATE287898T1
(de)
*
|
1991-04-05 |
2005-02-15 |
Gen Hospital Corp |
Parathyroid-hormon-rezeptor und seine kodierende dna
|
CA2153228A1
(en)
*
|
1993-01-08 |
1994-07-21 |
Shiu-Lan Ng Chiang |
Peptide inhibitors of cell adhesion
|
AU6235294A
(en)
*
|
1993-02-02 |
1994-08-29 |
Scripps Research Institute, The |
Methods for producing polypeptide binding sites
|
US6500924B1
(en)
|
1996-05-31 |
2002-12-31 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of angiogenesis
|
US5753230A
(en)
*
|
1994-03-18 |
1998-05-19 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of angiogenesis
|
US6056958A
(en)
*
|
1994-12-09 |
2000-05-02 |
Dupont Pharmaceuticals |
Method of treatment of arterial and venous thromboembolic disorders
|
ES2202336T3
(es)
*
|
1994-12-20 |
2004-04-01 |
Merck Patent Gmbh |
Anticuerpo monoclonal contra la integrina alfa-v.
|
US5817768A
(en)
*
|
1995-06-07 |
1998-10-06 |
The New York Blood Center, Inc. |
Monospecific antibodies against a subunit of fibrinogen
|
AU4134497A
(en)
*
|
1996-09-03 |
1998-03-26 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-integrin alpha3 antibody complexes
|
DE69739295D1
(de)
*
|
1996-12-09 |
2009-04-23 |
Merck Patent Gmbh |
Löslicher, rekombinanter alphaV beta3 Adhäsionsrezeptor
|
US20010011125A1
(en)
*
|
1997-01-30 |
2001-08-02 |
William D. Huse |
Anti-alpha v beta 3 recombinant human antibodies, nucleic acids encoding same and methods of use
|
US6590079B2
(en)
*
|
1997-01-30 |
2003-07-08 |
Ixsys, Incorporated |
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
CA2284518A1
(en)
|
1997-03-12 |
1998-09-17 |
Smithkline Beecham Corporation |
Anti-alphabeta3 humanized monoclonal antibodies
|
US6171588B1
(en)
|
1997-04-11 |
2001-01-09 |
G. D. Searle & Company |
Anti-αvβ3 integrin antibody antagonists
|
AU6954498A
(en)
*
|
1997-04-11 |
1998-11-11 |
G.D. Searle & Co. |
Methods for using antagonistic anti-avb3 integrin antibodies
|
US6210904B1
(en)
*
|
1997-10-14 |
2001-04-03 |
Merck & Co., Inc. |
Anticoagulant test
|
DE19828068C2
(de)
*
|
1998-06-24 |
2003-12-18 |
Peter Dietsch |
Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
|
CA2338283A1
(en)
*
|
1998-08-13 |
2000-02-24 |
G.D. Searle & Co. |
Multivalent avb3 and metastasis-associated receptor ligands
|
NZ511937A
(en)
*
|
1998-12-04 |
2004-02-27 |
Novartis Ag |
Methods and compositions for targeting an activated vitronectin receptor with a ligand comprising adenovirus-2 penton base or fragment thereof
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US7049140B1
(en)
|
1999-04-29 |
2006-05-23 |
Vanderbilt University |
X-ray guided drug delivery
|
US6159443A
(en)
*
|
1999-04-29 |
2000-12-12 |
Vanderbilt University |
X-ray guided drug delivery
|
US6531580B1
(en)
*
|
1999-06-24 |
2003-03-11 |
Ixsys, Inc. |
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
|
US6037176A
(en)
*
|
1999-06-25 |
2000-03-14 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of integrin beta 3 expression
|
JP2003508497A
(ja)
*
|
1999-09-08 |
2003-03-04 |
バイエル アクチェンゲゼルシャフト |
インテグリンに媒介される薬物ターゲッティング
|
EP1223980B1
(de)
*
|
1999-10-28 |
2003-05-21 |
Hofbauer, Reinhold |
Verwendung von csf-1-inhibitoren
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
DK1297016T3
(da)
*
|
2000-05-12 |
2006-07-10 |
Vlaams Interuniv Inst Biotech |
Anvendelse af placentavækstfaktorinhibitorer til behandling af patologisk angiogenese, patologisk arteriogenese, inflammation, tumordannelse og/eller vaskulær lækage
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
US7220824B1
(en)
|
2000-08-28 |
2007-05-22 |
Bayer Aktiengesellschaft |
Integrin-mediated drug targeting
|
EP1219305A1
(de)
*
|
2000-12-27 |
2002-07-03 |
Bayer Aktiengesellschaft |
Konjugate von Integrinrezeptorantagonisten und einem zytostatischen Mittel mit spezifisch spaltbaren Linkergruppen
|
MXPA03007878A
(es)
*
|
2001-03-02 |
2004-07-08 |
Medimmune Inc |
Metodos de prevencion o tratamiento de alteraciones inflamatorias o autoinmunes mediante la administracion de los antagonistas alfav, beta3 de integrina.
|
US7306925B2
(en)
|
2001-11-09 |
2007-12-11 |
Vanderbilt University |
Phage antibodies to radiation-inducible neoantigens
|
US7906102B2
(en)
|
2001-10-03 |
2011-03-15 |
Vanderbilt University |
Ligands to radiation-induced molecules
|
US8658773B2
(en)
|
2011-05-02 |
2014-02-25 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
EP1487492A4
(de)
*
|
2002-03-04 |
2008-10-01 |
Medimmune Inc |
Prävention oder behandlung von krebs mit integrin alphavbeta3 antagonisten in kombination mit anderen mitteln
|
JP2005525368A
(ja)
*
|
2002-03-04 |
2005-08-25 |
メディミューン,インコーポレーテッド |
インテグリンαvβ3アンタゴニストをHMG−CoA還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法
|
JP2005535572A
(ja)
*
|
2002-04-12 |
2005-11-24 |
メディミューン,インコーポレーテッド |
組換え抗インターロイキン−9抗体
|
EP1517704A1
(de)
*
|
2002-06-28 |
2005-03-30 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Verwendung von antikörpern gegen flt1 zur behandlung von osteoporose
|
US20050186204A1
(en)
*
|
2002-06-28 |
2005-08-25 |
Peter Carmeliet |
Use of antibodies against FLT-1 for the treatment of osteoporosis
|
CA2514653A1
(en)
*
|
2003-01-30 |
2004-08-12 |
Medimmune, Inc. |
Uses of integrin alphavbeta3 antagonists
|
CA2521826C
(en)
*
|
2003-04-11 |
2013-08-06 |
Jennifer L. Reed |
Recombinant il-9 antibodies and uses thereof
|
WO2005044978A2
(en)
*
|
2003-07-15 |
2005-05-19 |
Washington University |
Methods of treating, preventing and inhibiting cancer metastasis and tumor formation
|
US7271245B2
(en)
*
|
2004-02-13 |
2007-09-18 |
The Scripps Research Institute |
Methods and compositions for inhibition of metastasis
|
US7351739B2
(en)
*
|
2004-04-30 |
2008-04-01 |
Wellgen, Inc. |
Bioactive compounds and methods of uses thereof
|
US8187595B2
(en)
|
2004-05-07 |
2012-05-29 |
The University Of North Carolina At Chapel Hill |
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I
|
ES2343424T3
(es)
*
|
2004-05-07 |
2010-07-30 |
The University Of North Carolina At Chapel Hill |
Procedimiento para potenciar o inhibir el factor de crecimiento 1 similar a la insulina.
|
WO2005117978A2
(en)
|
2004-06-04 |
2005-12-15 |
Genentech, Inc. |
Method for treating multiple sclerosis
|
JP2008518023A
(ja)
|
2004-10-27 |
2008-05-29 |
メディミューン,インコーポレーテッド |
同族抗原に対する親和性を改変することによる抗体特異性の調節
|
JP5164829B2
(ja)
*
|
2005-03-24 |
2013-03-21 |
トロンボジェニクス・ナムローゼ・フエンノートシャップ |
新規な抗plgf抗体
|
US7867490B2
(en)
*
|
2005-06-30 |
2011-01-11 |
Vib Vzw |
Treatment of liver cirrhosis and its complications
|
MY149159A
(en)
|
2005-11-15 |
2013-07-31 |
Hoffmann La Roche |
Method for treating joint damage
|
WO2008011216A2
(en)
*
|
2006-05-16 |
2008-01-24 |
Pro-Pharmaceuticals, Inc. |
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
|
EP2851064A3
(de)
|
2006-07-11 |
2015-08-05 |
Roy C. Levitt |
Prävention und Therapie von Rhinosinusitis mit proinflammatorischen Zytokinhemmern
|
WO2008016431A2
(en)
*
|
2006-07-29 |
2008-02-07 |
Robert Lamar Bjork |
Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug
|
WO2008021237A1
(en)
|
2006-08-10 |
2008-02-21 |
Arubor Corporation |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
AR073295A1
(es)
|
2008-09-16 |
2010-10-28 |
Genentech Inc |
Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
|
JP5522717B2
(ja)
*
|
2008-09-19 |
2014-06-18 |
国立大学法人佐賀大学 |
アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法
|
AU2009299744B2
(en)
|
2008-10-02 |
2015-08-20 |
Life Sciences Research Partners Vzw |
Inhibition of PLGF to treat Philadelphia chromosome positive leukemia
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
WO2010075058A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Ge Healthcare Limited |
Application of 99mtc peptide-based compound as a bone marrow imaging agent
|
CA2749501C
(en)
|
2009-02-13 |
2017-01-10 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
US8287865B2
(en)
|
2009-09-16 |
2012-10-16 |
Immunomedics, Inc. |
Class I anti-CEA antibodies and uses thereof
|
WO2011068845A1
(en)
|
2009-12-02 |
2011-06-09 |
Immunomedics, Inc. |
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
|
EP2785739B1
(de)
|
2011-12-01 |
2017-03-15 |
ThromboGenics N.V. |
Verbesserung eines augendrucksenkungsergebnisses
|
WO2013101771A2
(en)
|
2011-12-30 |
2013-07-04 |
Genentech, Inc. |
Compositions and method for treating autoimmune diseases
|
WO2013116287A1
(en)
|
2012-01-31 |
2013-08-08 |
Genentech, Inc. |
Anti-ig-e m1' antibodies and methods using same
|
EP2885002A4
(de)
|
2012-08-14 |
2016-04-20 |
Ibc Pharmaceuticals Inc |
Umleitung t-zell-bispezifischer antikörper zur behandlung von krankheiten
|
MX2015002465A
(es)
|
2012-08-31 |
2015-11-06 |
Univ North Carolina |
Anticuerpos monoclonales para mejorar o inhibir factor de crecimiento 1 similar a insulina (igf-1).
|
SI2900277T1
(sl)
|
2012-12-13 |
2022-05-31 |
Immunomedics, Inc. |
Odmerki imunokonjugatov protiteles in SN-38 za boljšo učinkovitost in zmanjšano toksičnost
|
WO2014130648A1
(en)
|
2013-02-20 |
2014-08-28 |
Galectin Therapeutics, Inc. |
Method for treatment of pulmonary fibrosis
|
CN106132436B
(zh)
|
2014-02-21 |
2021-06-15 |
Ibc药品公司 |
通过诱导对trop-2表达细胞的免疫应答的疾病疗法
|
CN106029098A
(zh)
|
2014-02-25 |
2016-10-12 |
免疫医疗公司 |
人源化rfb4抗cd22抗体
|
US9580495B2
(en)
|
2014-06-24 |
2017-02-28 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
US10449261B2
(en)
|
2014-07-24 |
2019-10-22 |
Washington University |
Compositions targeting radiation-induced molecules and methods of use thereof
|
JP6678941B2
(ja)
|
2014-10-07 |
2020-04-15 |
イミューノメディクス、インコーポレイテッドImmunomedics, Inc. |
抗体−薬物コンジュゲートのネオアジュバント使用
|
JP6746845B2
(ja)
|
2015-04-22 |
2020-08-26 |
イミューノメディクス、インコーポレイテッドImmunomedics, Inc. |
循環trop−2陽性癌細胞の単離、検出、診断及び/または特徴付け
|
CN114796501A
(zh)
|
2015-06-25 |
2022-07-29 |
免疫医疗公司 |
抗体与治疗剂的组合治疗癌症的方法
|
SI3316885T1
(sl)
|
2015-07-01 |
2021-09-30 |
Immunomedics, Inc. |
Imunokonjugati protitelo-SN-38 z linkerjem CL2A
|
EP3359572A2
(de)
|
2015-10-06 |
2018-08-15 |
H. Hoffnabb-La Roche Ag |
Verfahren zur behandlung von multipler sklerose
|
EP3207937A1
(de)
|
2016-02-17 |
2017-08-23 |
Royal College of Surgeons in Ireland |
Verfahren zur behandlung oder prävention von sepsis
|
KR102101561B1
(ko)
*
|
2018-07-25 |
2020-04-20 |
가톨릭대학교 산학협력단 |
신생혈관 표적용 조영제 조성물 및 이의 제조방법
|
US20220133913A1
(en)
*
|
2019-07-24 |
2022-05-05 |
Korea Basic Science Institute |
SINGLE DOMAIN ANTIBODY TARGETING aVB3 INTEGRIN
|
WO2022157336A1
(en)
|
2021-01-22 |
2022-07-28 |
Royal College Of Surgeons In Ireland |
Treatment of coronavirus
|
WO2022239720A1
(ja)
|
2021-05-10 |
2022-11-17 |
公益財団法人川崎市産業振興財団 |
抗原への結合親和性を低減させた抗体
|